<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Matthew Arnold &#38; Baldwin LLP &#124; Giving you a lot more than just law... &#187; Mergers &amp; Acquisitions</title>
	<atom:link href="http://www.mablaw.com/category/Helping%20your%20business/mergers-acquisitions/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.mablaw.com</link>
	<description>MAB</description>
	<lastBuildDate>Thu, 17 May 2012 17:37:39 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0.4</generator>
		<item>
		<title>Government invites businesses to comment on company law regulations</title>
		<link>http://www.mablaw.com/2012/02/government-businesses-company-law-regulations-commercial-red-tape-challenge/</link>
		<comments>http://www.mablaw.com/2012/02/government-businesses-company-law-regulations-commercial-red-tape-challenge/#comments</comments>
		<pubDate>Wed, 08 Feb 2012 09:32:58 +0000</pubDate>
		<dc:creator>Richard Phillips</dc:creator>
				<category><![CDATA[Corporate]]></category>
		<category><![CDATA[Corporate Finance]]></category>
		<category><![CDATA[Corporate Structuring]]></category>
		<category><![CDATA[Directors' Duties]]></category>
		<category><![CDATA[Employer helpline]]></category>
		<category><![CDATA[Employment]]></category>
		<category><![CDATA[Mergers & Acquisitions]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[Selling your business]]></category>
		<category><![CDATA[Setting up your business]]></category>
		<category><![CDATA[Upload-Employment]]></category>
		<category><![CDATA[bureaucracy]]></category>
		<category><![CDATA[businesses]]></category>
		<category><![CDATA[companies]]></category>
		<category><![CDATA[Employers]]></category>
		<category><![CDATA[legislation]]></category>
		<category><![CDATA[Red Tape Challenge]]></category>
		<category><![CDATA[regulations]]></category>
		<category><![CDATA[small and medium-sized enterprises]]></category>
		<category><![CDATA[SMEs]]></category>

		<guid isPermaLink="false">http://www.mablaw.com/?p=19202</guid>
		<description><![CDATA[In the most recent instalment of its “Red Tape Challenge”, the Government has asked businesses to give their opinion on company legislation, with the aim of reducing the burden of regulation on UK businesses. The Red Tape Challenge is a website-based project aimed at identifying – and scrapping – unnecessary regulations. Over the past few [...]]]></description>
			<content:encoded><![CDATA[<p>In the most recent instalment of its “Red Tape Challenge”, the Government has asked businesses to give their opinion on company legislation, with the aim of reducing the burden of regulation on UK businesses.</p>
<p>The Red Tape Challenge is a website-based project aimed at identifying – and scrapping – unnecessary regulations. Over the past few months, the Government has been asking interested parties to submit a response on the website, suggesting which regulations across various sectors should be scrapped, merged with other regulations, simplified, or improved. The focus is now on company law regulations. Further details on the Red Tape Challenge are <a href="http://www.mablaw.com/2011/04/government-launches-red-tape-challenge-in-order-to-reduce-unnecessary-regulation/">here</a>.</p>
<p>The Department for Business, Innovation and Skills (BIS) has invited comments on how it might reduce the administrative burden placed on UK businesses, whilst continuing to provide adequate protection for creditors, customers and suppliers. It highlights approximately 120 pieces of company legislation for review, under four headings: The Workings of Companies and Partnerships; Accounts and Returns; Business Names; and Disclosing Information about your Business. Comments can be made <a href="http://www.redtapechallenge.cabinetoffice.gov.uk/themehome/company-commercial-law/">here</a>.</p>
<p>BIS has also published a Discussion Paper, <em><a href="http://www.bis.gov.uk/assets/biscore/business-law/docs/c/12-560-company-law-flexible-framework-discussion-paper.pdf">Providing a flexible framework which allows companies to compete and grow</a></em>, which seeks views on how the company law framework can be improved in all areas. The Discussion Paper poses a number of questions in relation to the possible improvement in the following further areas of company law. These include:</p>
<p>1.<strong> Company names.</strong> BIS asks for views on whether the law on company names causes problems and delay;</p>
<p>2.<strong> Company filings.</strong> BIS asks whether it would be beneficial to be able to file an annual return and accounts together and how the system should change to best accommodate that;</p>
<p>3.<strong> Rights to inspect company registers.</strong> BIS asks for suggestions to improve, in practice, how registers may be inspected;</p>
<p>4.<strong> Penalties and enforcement.</strong> BIS asks whether the existing UK system of setting of fines and penalties is the most appropriate method for achieving compliance with the law; and</p>
<p>5.<strong> Employee share schemes.</strong> BIS asks whether existing company law as regards the design and operation of company share ownership schemes requires amendment or simplification.</p>
<p>The Red Tape Challenge is focusing on company law until 16 February 2012, but comments on UK regulation can be made after this date (although it is not clear to what extent the Government will take account of comments it receives after 16 February.) The Discussion Paper does not specify a date by which the Government must receive responses to the specific questions posed.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.mablaw.com/2012/02/government-businesses-company-law-regulations-commercial-red-tape-challenge/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Protect Your Position – Bristol-Myers buys Inhibitex for $2.5 billion</title>
		<link>http://www.mablaw.com/2012/01/bristol-myers-inhibitex-patent-cliff/</link>
		<comments>http://www.mablaw.com/2012/01/bristol-myers-inhibitex-patent-cliff/#comments</comments>
		<pubDate>Tue, 17 Jan 2012 17:45:13 +0000</pubDate>
		<dc:creator>Laura Mole</dc:creator>
				<category><![CDATA[Corporate]]></category>
		<category><![CDATA[Intellectual Property]]></category>
		<category><![CDATA[Inventions]]></category>
		<category><![CDATA[Mergers & Acquisitions]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[Pharmaceutical]]></category>
		<category><![CDATA[Upload-Pharma]]></category>
		<category><![CDATA[acquisitions]]></category>
		<category><![CDATA[big pharma]]></category>
		<category><![CDATA[commercial]]></category>
		<category><![CDATA[commercial contracts]]></category>
		<category><![CDATA[contract]]></category>
		<category><![CDATA[corporate]]></category>
		<category><![CDATA[hepatitis C]]></category>
		<category><![CDATA[Intellectual property]]></category>
		<category><![CDATA[intellectual property rights]]></category>
		<category><![CDATA[IP]]></category>
		<category><![CDATA[IP protection]]></category>
		<category><![CDATA[IP rights]]></category>
		<category><![CDATA[IPR]]></category>
		<category><![CDATA[M&A]]></category>
		<category><![CDATA[medicine patent]]></category>
		<category><![CDATA[medicines]]></category>
		<category><![CDATA[medicines patent]]></category>
		<category><![CDATA[merger]]></category>
		<category><![CDATA[merger and acquisitions]]></category>
		<category><![CDATA[Mergers and acquisitions]]></category>
		<category><![CDATA[patent]]></category>
		<category><![CDATA[patent cliff]]></category>
		<category><![CDATA[patent law]]></category>
		<category><![CDATA[patented]]></category>
		<category><![CDATA[Patents]]></category>
		<category><![CDATA[Patents Act 1977]]></category>
		<category><![CDATA[pharma]]></category>
		<category><![CDATA[pharma products]]></category>
		<category><![CDATA[pharmaceutical]]></category>
		<category><![CDATA[pharmaceutical business]]></category>
		<category><![CDATA[pharmaceutical company]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>
		<category><![CDATA[pharmaceutical market]]></category>
		<category><![CDATA[pharmaceutical patents]]></category>
		<category><![CDATA[pharmaceutical products]]></category>
		<category><![CDATA[pharmaceutical sector]]></category>

		<guid isPermaLink="false">http://www.mablaw.com/?p=18994</guid>
		<description><![CDATA[With the Patent Cliff looming and the lack of new drugs to fill the void keeping big Pharma bosses awake at night, we are seeing new strategies emerging in an attempt to off see the gloom and doom predictions of some Pharma theorists. One such strategy is the utilization of opportunities presented by small and [...]]]></description>
			<content:encoded><![CDATA[<p>With the Patent Cliff looming and the lack of new drugs to fill the void keeping big Pharma bosses awake at night, we are seeing new strategies emerging in an attempt to off see the gloom and doom predictions of some Pharma theorists. One such strategy is the utilization of opportunities presented by small and mid-sized Pharma companies who specialise in new drug development and niche markets.</p>
<p>One opportunity has been seized by big Pharma company, Bristol-Myers Squibb, through its recent acquisition of Inhibitex, a biopharmaceutical company, at a cost of US$2.5 billion. Inhibitex is currently developing a promising new hepatitis C drug, which though currently only in Phase II development has shown great potential. With over 150 million people worldwide suffering from hepatitis C and over 75% of liver disease being attributed to the illness, producing an effective drug to combat or manage the disease is foremost in the mind of the Pharma industry today; and Bristol-Myers Squibb is not alone. Only last November, Gilead Sciences, Inc agreed to pay US$11 billion for Pharmasset, Inc, another company refocusing on the development of further hepatitis C treatments and with Merck, Vertex and Johnson &amp; Johnson also rumoured to be targeting the hepatitis C market, we can see that big Pharma are on the hunt.</p>
<p>Laura Mole, a member of MAB’s Pharmaceutical and Life Sciences Sector team says, “This latest acquisition by Bristol-Myers Squibb is living proof that the industry is changing and big Pharma are almost panic buying in order to build and diversify their portfolios. This is shown by the acquisition of not only market ready products but also drugs still in the development stages. It is clear that with the Patent Cliff threatening, and with Bristol-Myers Squibb itself to fall victim with its soon-to-expire patent protection on blockbuster drug Plavix, any opportunity to grow and protect will be taken. Small/mid sized Pharma had better be ready for the bidding war to come.”</p>
]]></content:encoded>
			<wfw:commentRss>http://www.mablaw.com/2012/01/bristol-myers-inhibitex-patent-cliff/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>“The Patent Cliff – Lipitor goes over the Edge”</title>
		<link>http://www.mablaw.com/2011/12/patent-cliff-pfizer-lipitor-atorvastatin/</link>
		<comments>http://www.mablaw.com/2011/12/patent-cliff-pfizer-lipitor-atorvastatin/#comments</comments>
		<pubDate>Mon, 12 Dec 2011 17:43:25 +0000</pubDate>
		<dc:creator>Laura Mole</dc:creator>
				<category><![CDATA[Brands]]></category>
		<category><![CDATA[Intellectual Property]]></category>
		<category><![CDATA[International]]></category>
		<category><![CDATA[Inventions]]></category>
		<category><![CDATA[Mergers & Acquisitions]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[Pharmaceutical]]></category>
		<category><![CDATA[Upload-Commercial/IP/IT]]></category>
		<category><![CDATA[Upload-Pharma]]></category>
		<category><![CDATA[brand]]></category>
		<category><![CDATA[brand protection]]></category>
		<category><![CDATA[branding]]></category>
		<category><![CDATA[brands]]></category>
		<category><![CDATA[Commercial contract]]></category>
		<category><![CDATA[contract]]></category>
		<category><![CDATA[generic]]></category>
		<category><![CDATA[generic drugs]]></category>
		<category><![CDATA[generics]]></category>
		<category><![CDATA[infringement]]></category>
		<category><![CDATA[Intellectual property]]></category>
		<category><![CDATA[intellectual property rights]]></category>
		<category><![CDATA[intellectual property rights infringement]]></category>
		<category><![CDATA[IP]]></category>
		<category><![CDATA[IP infringement]]></category>
		<category><![CDATA[IPR infringement]]></category>
		<category><![CDATA[medicine patent]]></category>
		<category><![CDATA[medicines patent]]></category>
		<category><![CDATA[patent]]></category>
		<category><![CDATA[patent cliff]]></category>
		<category><![CDATA[patent infringement]]></category>
		<category><![CDATA[patent law]]></category>
		<category><![CDATA[patented]]></category>
		<category><![CDATA[Patents]]></category>
		<category><![CDATA[Patents Act 1977]]></category>
		<category><![CDATA[pharmaceutical patents]]></category>
		<category><![CDATA[unauthorised]]></category>
		<category><![CDATA[unlawful]]></category>

		<guid isPermaLink="false">http://www.mablaw.com/?p=18741</guid>
		<description><![CDATA[As the largest ever number of patents protecting the pharmaceutical industry’s most profitable “blockbuster” drugs are set to expire, for India and China it’s going to be a very merry Christmas and an even better New Year. India and China both have an established and successful generics based pharmaceutical industry and as tens of billions [...]]]></description>
			<content:encoded><![CDATA[<p>As the largest ever number of patents protecting the pharmaceutical industry’s most profitable “blockbuster” drugs are set to expire, for India and China it’s going to be a very merry Christmas and an even better New Year.</p>
<p>India and China both have an established and successful generics based pharmaceutical industry and as tens of billions of pounds of  patent protected drugs come off patent soon (known as the “patent cliff”), they look set to benefit by releasing cheaper generic  alternatives &#8211; making themselves a small fortune in the process. Both the Wall Street Journal and BBC News have reported on the most recent victim of the patent cliff in which India-based firm Ranbaxy Laboratories Limited confirmed the release of an FDA-approved generic version of the 10 billion dollar a year drug “Lipitor” owned by the global pharmaceutical company, Pfizer. The new generic drug will be called “Atorvastatin” and with Lipitor’s patent having now expired, there is nothing Pfizer can do about it – except try to develop itself or buy in the next big thing from another research and developer.</p>
<p>With such a Robin Hood approach to pharmaceuticals there are mixed opinions about the impact the patent cliff is having on the pharmaceutical industry as a whole. The large pharmaceutical companies claim that the patent cliff is affecting their ability to raise funds for research and development which in turn is inhibiting advances in new and improved pharmaceuticals, to the detriment of patients. The smaller generic based companies and some consumer groups however are hailing the patent cliff as an opportunity to offer a wider-ranging and affordable selection of medicines to both the public and private sectors.</p>
<p>Laura Mole, from Matthew Arnold and Baldwin LLP’s Pharmaceutical and Life Sciences Sector Group Team, says, “Whilst I appreciate continued research and development in the pharmaceutical industry as a whole is vital for the production of new, more advanced drugs to combat human illness, I cannot help but see good quality, affordable alternative medicines as a good thing for the consumer and the NHS in these difficult financial times. More drugs will cost less so more patients will benefit. The important thing in the long-term, though, is that there is sufficient funding in the industry to incentivise continued research and development so that patients continue to benefit with further medical advances. More of the early-stage development is being done by start-up companies, with big pharma companies stepping in if the prospects look good.”</p>
]]></content:encoded>
			<wfw:commentRss>http://www.mablaw.com/2011/12/patent-cliff-pfizer-lipitor-atorvastatin/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Court interprets that pharma company sellers had been reasonable in refusing to consent to provision stopping sale of product that gave them an earn-out – Porton Capital Technology Funds v 3M UK, High Court</title>
		<link>http://www.mablaw.com/2011/11/pharma-porton-3muk-mrsa-acolyte-baclite/</link>
		<comments>http://www.mablaw.com/2011/11/pharma-porton-3muk-mrsa-acolyte-baclite/#comments</comments>
		<pubDate>Mon, 14 Nov 2011 08:08:56 +0000</pubDate>
		<dc:creator>Paul Gershlick</dc:creator>
				<category><![CDATA[Commercial Contracts]]></category>
		<category><![CDATA[Mergers & Acquisitions]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[Pharmaceutical]]></category>
		<category><![CDATA[Upload-Commercial/IP/IT]]></category>
		<category><![CDATA[consent]]></category>
		<category><![CDATA[High Court]]></category>
		<category><![CDATA[pharma]]></category>
		<category><![CDATA[pharma products]]></category>
		<category><![CDATA[pharmaceutical]]></category>
		<category><![CDATA[pharmaceutical business]]></category>
		<category><![CDATA[pharmaceutical company]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>
		<category><![CDATA[pharmaceutical market]]></category>
		<category><![CDATA[pharmaceutical products]]></category>
		<category><![CDATA[pharmaceutical sector]]></category>
		<category><![CDATA[prior consent]]></category>
		<category><![CDATA[reasonable]]></category>
		<category><![CDATA[reasonableness]]></category>
		<category><![CDATA[reasonably]]></category>
		<category><![CDATA[refusal]]></category>
		<category><![CDATA[refuse]]></category>
		<category><![CDATA[unreasonable]]></category>
		<category><![CDATA[unreasonably]]></category>
		<category><![CDATA[withheld]]></category>

		<guid isPermaLink="false">http://www.mablaw.com/?p=17090</guid>
		<description><![CDATA[3M UK had purchased the shares of Acolyte under a share purchase agreement, where the majority shareholder had previously been Porton. Acolyte’s product was BacLite MRSA, a test process and technology designed to detect the MRSA bug in hospitals. The initial purchase price for the shares was £10 million, with up to a further £41m [...]]]></description>
			<content:encoded><![CDATA[<p>3M UK had purchased the shares of Acolyte under a share purchase agreement, where the majority shareholder had previously been Porton. Acolyte’s product was BacLite MRSA, a test process and technology designed to detect the MRSA bug in hospitals. The initial purchase price for the shares was £10 million, with up to a further £41m to earn based on net sales in 2009. 3M UK agreed to procure that Acolyte would not cease to carry on its business relating to developing and marketing BacLite without the prior written consent of the sellers, such consent not to be unreasonably withheld. The business did not go well and 3M UK wrote to the sellers asking for consent to cease the business. The sellers said that would be fine if they received their £41m payment. 3M UK offered about £1m instead. The parties reached deadlock and 3M UK stopped the BacLite business. There were no sales in 2009 and so no further payments due. The sellers sued for breach of contract.</p>
<p>The High Court has sided with the previous owners of the pharma business. Applying the principles from landlord and tenant cases in relation to interpretation of the phrase “not to be unreasonably withheld”, it said:</p>
<ul>
<li>The burden had been on 3M UK to prove that the refusal of consent was unreasonable.</li>
<li>The sellers did not have to show that their consent was justified – only what someone in his position would reasonably have done in the circumstances. It was no surprise that the sellers had viewed 3M UK’s statements and profit projections with scepticism and it was reasonable for them to expect far clearer evidence of future figures.</li>
<li>In deciding what was reasonable, the sellers only had to consider their own interests in earning as large a payment as possible. This was the case unless the benefit to one party was so disproportionate to the detriment of the other.</li>
<li>The sellers did not have to balance their interests with anyone else’s in coming to that conclusion.</li>
</ul>
]]></content:encoded>
			<wfw:commentRss>http://www.mablaw.com/2011/11/pharma-porton-3muk-mrsa-acolyte-baclite/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>High Court rules on non-solicitation clause</title>
		<link>http://www.mablaw.com/2011/07/high-court-rules-on-non-solicitation-clause/</link>
		<comments>http://www.mablaw.com/2011/07/high-court-rules-on-non-solicitation-clause/#comments</comments>
		<pubDate>Mon, 18 Jul 2011 20:30:44 +0000</pubDate>
		<dc:creator>Emma Cameron</dc:creator>
				<category><![CDATA[Corporate]]></category>
		<category><![CDATA[Corporate Finance]]></category>
		<category><![CDATA[Corporate Structuring]]></category>
		<category><![CDATA[Mergers & Acquisitions]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[Restrictive Covenants]]></category>
		<category><![CDATA[Selling your business]]></category>
		<category><![CDATA[Business sale]]></category>
		<category><![CDATA[corporate]]></category>
		<category><![CDATA[corporate finance]]></category>
		<category><![CDATA[Share sale]]></category>

		<guid isPermaLink="false">http://www.mablaw.com/?p=12136</guid>
		<description><![CDATA[Background When a buyer purchases a business, it usually wishes to ensure that the seller cannot compete with the business of the target post-sale. We therefore recommend that restrictive covenants are included in any sale and purchase agreement. Facts of the case In this case the restrictive covenants in the sale and purchase agreement included a [...]]]></description>
			<content:encoded><![CDATA[<p><strong>Background </strong></p>
<p>When a buyer purchases a business, it usually wishes to ensure that the seller cannot compete with the business of the target post-sale. We therefore recommend that restrictive covenants are included in any sale and purchase agreement.</p>
<p><strong>Facts of the case</strong></p>
<p>In this case the restrictive covenants in the sale and purchase agreement included a non-solicitation clause which prohibited the defendant from soliciting, canvassing or enticing away the customers of the target business for three years following completion. Before that three year period ended, the claimant noticed that some of its clients were moving to the firm where the defendant now worked. Clients had never moved to that firm before and the claimant issued proceedings for breach of restrictive covenant by the defendant.</p>
<p><strong>Decision</strong></p>
<p>The High Court ruled that the restrictive covenant had been breached due to the defendant&#8217;s actions and intentions on the following ground that the evidence showed that:</p>
<p>- there was a secret intention between the defendant and his new employer of an intention to acquire the claimant&#8217;s client base and a clear intention of the defendant to solicit the claimant&#8217;s clients for his new employer; and</p>
<p>- there were a number of clear actions by the defendant which solicited the clients for his new employer, including calling and meeting clients and encouraging them to follow his move.</p>
<p>The High Court considered that no client could have been guaranteed to stay with the claimant firm for more than one year but ruled that damages should be payable to reflect that one year&#8217;s revenue, such that the defendant was liable to pay damages of £31,875.</p>
<p><strong>Comment</strong></p>
<p>This case shows the importance of putting restrictive covenants into a sale and purchase agreement. Restrictive covenants must be very carefully drafted so as to be reasonable when considering their length, geographical effect and scope, and are interpreted on a case-by-case basis by the court, but this case highlights that time spent drafting such provisions can be time well spent.</p>
<p><em>Baldwins (Ashby) Ltd v Maidstone</em></p>
]]></content:encoded>
			<wfw:commentRss>http://www.mablaw.com/2011/07/high-court-rules-on-non-solicitation-clause/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>OFT investigates gaming acquisition for competition breach</title>
		<link>http://www.mablaw.com/2011/06/oft-competition-breach-barcrest/</link>
		<comments>http://www.mablaw.com/2011/06/oft-competition-breach-barcrest/#comments</comments>
		<pubDate>Tue, 14 Jun 2011 20:44:46 +0000</pubDate>
		<dc:creator>Simon Weinberg</dc:creator>
				<category><![CDATA[Mergers & Acquisitions]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[Upload-Commercial/IP/IT]]></category>
		<category><![CDATA[acquisition]]></category>
		<category><![CDATA[anti-competition]]></category>
		<category><![CDATA[anti-competitive]]></category>
		<category><![CDATA[breach]]></category>
		<category><![CDATA[competition]]></category>
		<category><![CDATA[competition law]]></category>
		<category><![CDATA[competition law breach]]></category>
		<category><![CDATA[competition law regime]]></category>
		<category><![CDATA[competition regime]]></category>
		<category><![CDATA[market share]]></category>
		<category><![CDATA[Office of Fair Trading]]></category>
		<category><![CDATA[OFT]]></category>
		<category><![CDATA[OFT investigation]]></category>

		<guid isPermaLink="false">http://www.mablaw.com/?p=10201</guid>
		<description><![CDATA[In May, the US-based Scientific Games Corporation (SGC) agreed to buy Barcrest, a UK-based manufacturer of gaming and amusement arcade machines with operations throughout Europe. The Office of Fair Trading has now announced that it is investigating whether the acquisition would breach competition law on the grounds that it might result in a substantial lessening [...]]]></description>
			<content:encoded><![CDATA[<p>In May, the US-based Scientific Games Corporation (SGC) agreed to buy Barcrest, a UK-based manufacturer of gaming and amusement arcade machines with operations throughout Europe. The Office of Fair Trading has now announced that it is investigating whether the acquisition would breach competition law on the grounds that it might result in a substantial lessening of competition in the gaming and amusement machines market.</p>
<p>SGC owns two other UK-based gaming and amusement machine operators – The Global Draw and Games Media. Global Draw is estimated to have a 43% share of the gaming and amusement machine market.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.mablaw.com/2011/06/oft-competition-breach-barcrest/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>How difficult is it to gift a share?</title>
		<link>http://www.mablaw.com/2011/03/how-difficult-is-it-to-gift-a-share/</link>
		<comments>http://www.mablaw.com/2011/03/how-difficult-is-it-to-gift-a-share/#comments</comments>
		<pubDate>Thu, 03 Mar 2011 14:35:18 +0000</pubDate>
		<dc:creator>Samantha Lloyd</dc:creator>
				<category><![CDATA[Accountants]]></category>
		<category><![CDATA[Corporate]]></category>
		<category><![CDATA[Corporate Finance]]></category>
		<category><![CDATA[Corporate Restructure]]></category>
		<category><![CDATA[Corporate Structuring]]></category>
		<category><![CDATA[Mergers & Acquisitions]]></category>
		<category><![CDATA[Wealth Management]]></category>
		<category><![CDATA[corporate]]></category>
		<category><![CDATA[gift]]></category>
		<category><![CDATA[registration]]></category>
		<category><![CDATA[shares]]></category>
		<category><![CDATA[transfer]]></category>
		<category><![CDATA[trust]]></category>

		<guid isPermaLink="false">http://www.mablaw.com/?p=8307</guid>
		<description><![CDATA[Background How difficult is it to gift a share? This was the question asked by Lady Justice Arden in her judgment in Shah v Shah [2010] EWCA Civ 140. The case considered whether or not a letter accompanied by an incomplete stock transfer form manifested an intention to make a gift or an intention to [...]]]></description>
			<content:encoded><![CDATA[<p><strong>Background</strong></p>
<p>How difficult is it to gift a share? This was the question asked by Lady Justice Arden in her judgment in Shah v Shah [2010] EWCA Civ 140. The case considered whether or not a letter accompanied by an incomplete stock transfer form manifested an intention to make a gift or an intention to create a trust.</p>
<p>Until a transfer of shares is registered in the statutory books of a company, the transferor remains the legal owner of the shares. Therefore, a gift of the legal interest in a share is not complete until registration has taken place. However, a transferor can transfer the beneficial interest in a share prior to the transfer of the legal interest by declaring that they are holding that share on trust for the transferee.</p>
<p><strong>Facts of the case</strong></p>
<p>After a family feud and successive litigation two brothers (D and R) executed and delivered identical letters and stock transfer forms each purporting to dispose of 4,000 shares in a company in favour of their brother (M). However, the stock transfer forms were left undated and the consideration (being the money or monies worth provided in exchange for the transfer) was left blank. The company subsequently completed the stock transfer forms and registered the shares in M’s name. The case went back to court because D challenged his disposition to M on the basis that the letter he signed constituted a gift and as the gift was not completely constituted, it was of no effect.</p>
<p>The letter stated:</p>
<p><em>“This letter is to confirm that out of my shareholding of current 12,500.00 in the above company I am as from today holding 4,000 shares in the above company for you subject to you being responsible for all tax consequences and liabilities [arising] from this declaration and letter.”</em></p>
<p><strong>Decision</strong></p>
<p>The Court considered the words used in the letter in the context of all of the relevant facts rather than the alleged subjective intentions of D. On that basis, the Court found that there was no question that the words demonstrated an intention to dispose of the shares immediately by the use of the words “as from today”. However, the effect of the words “as from today” in law was to dispose of the beneficial interest only at that point as legal title did not pass until registration. The use of words “I am holding” as opposed to “I am assigning” or “I am giving” and the concept that D held the shares for M until he lost that status on registration could only be given effect in law by the imposition of a trust. On that basis the court found that D must be taken in law to have intended a trust and not a gift. The Court went on to find that D had intended that registration of the transfer would take place in due course otherwise why would he have also executed and delivered a signed but undated stock transfer form?</p>
<p><strong>Comment</strong></p>
<p>Returning to the original question in her judgment, Lady Justice Arden concluded that it is not difficult to make a gift of shares but it may take time to complete the gift by registration of the shares in the name of the transferee. If you want to make an immediate gift, one way of doing so is to declare a trust.<strong></strong></p>
]]></content:encoded>
			<wfw:commentRss>http://www.mablaw.com/2011/03/how-difficult-is-it-to-gift-a-share/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Share Transfers: Only Bona Fide Transactions Will Suffice</title>
		<link>http://www.mablaw.com/2011/02/share-transfers-only-bona-fide-transactions-will-suffice/</link>
		<comments>http://www.mablaw.com/2011/02/share-transfers-only-bona-fide-transactions-will-suffice/#comments</comments>
		<pubDate>Tue, 15 Feb 2011 14:19:28 +0000</pubDate>
		<dc:creator>Mark Archer</dc:creator>
				<category><![CDATA[Accountants]]></category>
		<category><![CDATA[Banking & Finance]]></category>
		<category><![CDATA[Corporate]]></category>
		<category><![CDATA[Corporate Finance]]></category>
		<category><![CDATA[Corporate Restructure]]></category>
		<category><![CDATA[Corporate Structuring]]></category>
		<category><![CDATA[MBOs & MBIs]]></category>
		<category><![CDATA[Mergers & Acquisitions]]></category>
		<category><![CDATA[Shareholders]]></category>
		<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[banks]]></category>
		<category><![CDATA[contract law]]></category>
		<category><![CDATA[corporate]]></category>
		<category><![CDATA[unauthorised]]></category>
		<category><![CDATA[unlawful]]></category>

		<guid isPermaLink="false">http://www.mablaw.com/?p=7361</guid>
		<description><![CDATA[A recent High Court case has highlighted that a purported gift of shares in a company by one of the company&#8217;s directors which was intended to put those shares beyond the reach of individuals who may have had a claim against him, was unlawful and could be set aside. Where, as in this case, the fundamental motivation [...]]]></description>
			<content:encoded><![CDATA[<p>A recent High Court case has highlighted that a purported gift of shares in a company by one of the company&#8217;s directors which was intended to put those shares beyond the reach of individuals who may have had a claim against him, was unlawful and could be set aside.</p>
<p>Where, as in this case, the fundamental motivation for the transfer was a fear on the part of the director that he was going to be subject to a major claim against him arising out of his misappropriation of funds in a bank account in respect of which he had fiduciary obligations, the director could not of his own volition tranfer some of his shares in the company by way of a gift to his daughter and wife.  The company had not authorised the director to issue share certificates to his wife or daughter or to record them as shareholders in the company&#8217;s register of members. Accordingly, legal title had not been effectively transferred.  In effecting the gifts, the director had tried, without success, to realise an immediate and outright transfer of his beneficial interest. However, no amount of benevolent construction of those transactions could lead to a conclusion that the director was intending to declare himself a trustee in respect of  his shareholding. Moreover, the director had failed to take the necessary steps sufficient to enable his wife and daughter to obtain a transfer of the shareholding without further recourse to assistance from him. All they received were documents purporting to be new share certificates in their names which the director had created without the company&#8217;s authority. The result was that, without the director&#8217;s assistance in making available the duly completed stock transfer forms, neither his wife nor his daughter could perfect the intended gifts. Accordingly, no beneficial interest had been transferred.</p>
<p>This case highlights once again that people trying to put their personal assets (in this case shares) beyond the reach of creditors will come unstuck if their motivation is to defeat the interests of those creditors. Furthermore, the case also highlights the importance of company board meetings approving share transfers. A proper transfer of shares requires: (i) the transfer to be approved by the directors passing the requisite resolution (usually at a duly convened board meeting, but as an alternative, the resolution could be passed by directors&#8217; unanimous written resolution); and (2) the directors also resolving to approve a person (normally another director or the company secretary) to deal with the mechanics of recording the transfer in the company&#8217;s statutory records, and to issue new share certificates. Furthermore, if a transferee only wishes to transfer the beneficial and not the legal title, then he or she should enter into an appropriate trust instrument, for example, a Declaration of Trust over the shares, clearly setting out who the beneficiaries are and the exact details of the shares which are the subject the trust. Otherwise, as this case highlights, going forward there could be be serious question marks over the validity of the share transfer as well as the the validity of any purported transfer of the legal and/or beneficial title to the shares.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.mablaw.com/2011/02/share-transfers-only-bona-fide-transactions-will-suffice/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>European Commission approves acquisition of McAfee by Intel</title>
		<link>http://www.mablaw.com/2011/02/european-commission-mcafee-intel/</link>
		<comments>http://www.mablaw.com/2011/02/european-commission-mcafee-intel/#comments</comments>
		<pubDate>Wed, 02 Feb 2011 17:52:24 +0000</pubDate>
		<dc:creator>Simon Weinberg</dc:creator>
				<category><![CDATA[Commercial Contracts]]></category>
		<category><![CDATA[Corporate]]></category>
		<category><![CDATA[Corporate Finance]]></category>
		<category><![CDATA[IT]]></category>
		<category><![CDATA[Mergers & Acquisitions]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[Online]]></category>
		<category><![CDATA[Software]]></category>
		<category><![CDATA[Upload-Commercial/IP/IT]]></category>
		<category><![CDATA[Websites]]></category>
		<category><![CDATA[anti-competition]]></category>
		<category><![CDATA[anti-competitive]]></category>
		<category><![CDATA[breach of competition law]]></category>
		<category><![CDATA[central processing unit]]></category>
		<category><![CDATA[chip]]></category>
		<category><![CDATA[competition]]></category>
		<category><![CDATA[competition law]]></category>
		<category><![CDATA[competition regime]]></category>
		<category><![CDATA[competitor]]></category>
		<category><![CDATA[competitors]]></category>
		<category><![CDATA[CPU]]></category>
		<category><![CDATA[data security]]></category>
		<category><![CDATA[EC]]></category>
		<category><![CDATA[EC Merger Regulation]]></category>
		<category><![CDATA[European Commission]]></category>
		<category><![CDATA[hardware]]></category>
		<category><![CDATA[Internet security]]></category>
		<category><![CDATA[merger]]></category>
		<category><![CDATA[Merger Regulation]]></category>
		<category><![CDATA[Mergers and acquisitions]]></category>
		<category><![CDATA[unfair competition]]></category>

		<guid isPermaLink="false">http://www.mablaw.com/?p=7113</guid>
		<description><![CDATA[The European Commission (EC) has given its conditional approval to the proposed acquisition of McAfee, the security technology company, by Intel. Intel is one of the big players in the worldwide computer manufacturing market, in particular as one of the biggest manufacturers of central processing units (CPUs). The EC&#8217;s decision shows that there were serious [...]]]></description>
			<content:encoded><![CDATA[<p>The European Commission (EC) has given its conditional approval to the proposed acquisition of McAfee, the security technology company, by Intel. Intel is one of the big players in the worldwide computer manufacturing market, in particular as one of the biggest manufacturers of central processing units (CPUs).</p>
<p>The <span style="text-decoration: underline;"><a href="http://europa.eu/rapid/pressReleasesAction.do?reference=IP/11/70&amp;format=HTML&amp;aged=0&amp;language=EN&amp;guiLanguage=en">EC&#8217;s decision</a></span> shows that there were serious competition concerns in relation to the merger, in particular with regards to the potential bundling of CPUs from Intel with the security products produced by McAfee, if such bundling did not allow for interoperability of the McAfee security products with the CPUs manufactured by Intel’s competitors and vice versa.</p>
<p>As a result, the EC gave its conditional approval to the acquisition under <span style="text-decoration: underline;"><a href="http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=CELEX:32004R0139:EN:HTML">the EC Merger Regulation</a></span>, the conditions being that such interoperability be possible and all necessary information for interoperability be made available to Intel’s, and McAfee’s, competitors.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.mablaw.com/2011/02/european-commission-mcafee-intel/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Government consults on draft Companies (Reporting Requirements in Mergers and Divisions) Regulations 2011</title>
		<link>http://www.mablaw.com/2011/01/consultation-draft-companies-reporting-requirements-in-mergers-and-divisions-regulations-2011-directive-bis-june-2011/</link>
		<comments>http://www.mablaw.com/2011/01/consultation-draft-companies-reporting-requirements-in-mergers-and-divisions-regulations-2011-directive-bis-june-2011/#comments</comments>
		<pubDate>Mon, 17 Jan 2011 16:30:16 +0000</pubDate>
		<dc:creator>Richard Phillips</dc:creator>
				<category><![CDATA[Corporate]]></category>
		<category><![CDATA[Corporate Restructure]]></category>
		<category><![CDATA[Corporate Structuring]]></category>
		<category><![CDATA[Directors' Duties]]></category>
		<category><![CDATA[Mergers & Acquisitions]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[Shareholders]]></category>
		<category><![CDATA[(Reporting Requirements in Mergers and Divisions) Regulations 2011]]></category>
		<category><![CDATA[cross-border]]></category>
		<category><![CDATA[divisions]]></category>
		<category><![CDATA[electronic communications]]></category>
		<category><![CDATA[merger]]></category>
		<category><![CDATA[Mergers and acquisitions]]></category>
		<category><![CDATA[share capital]]></category>

		<guid isPermaLink="false">http://www.mablaw.com/?p=6866</guid>
		<description><![CDATA[The Department for Business, Innovation and Skills (BIS) has asked for comments on the draft Companies (Reporting Requirements in Mergers and Divisions) Regulations 2011. These Regulations will implement in the UK the 2009 EU Directive on reporting and documentation requirements in the case of mergers and divisions, which must be done by 30 June 2011. [...]]]></description>
			<content:encoded><![CDATA[<p>The Department for Business, Innovation and Skills (BIS) has asked for comments on the <em>draft Companies (Reporting Requirements in Mergers and Divisions) Regulations 2011</em>.</p>
<p>These Regulations will implement in the UK the 2009 EU Directive on reporting and documentation requirements in the case of mergers and divisions, which must be done by <strong>30 June 2011</strong>. This Directive makes various deregulatory amendments to several other EU directives, with the aim of simplifying some of the processes on public company mergers, the formation and capital of public companies, and cross-border mergers, by enabling companies to make use of new technology, removing over-regulation and protecting creditors.</p>
<p>The Regulations will amend Parts 17 (A company&#8217;s share capital) and 27 (Mergers and Divisions of public companies) of the <em>Companies Act 2006</em>, and also the <em>Companies (Cross-Border Mergers) Regulations 2007</em>.</p>
<p>It is hoped that the Regulations will reduce the administrative burden on companies. This includes, amongst other things:</p>
<p>1. <strong>Taking advantage of technology</strong>. Companies will be able to make use of electronic communications for the circulation of certain documents that would previously have had to be made available, or filed, in hard copy format. For example, documents will be able to be published on a company’s website or sent to shareholders electronically; and</p>
<p>2. <strong>Removing overregulation</strong>. A reduction in the need for companies to produce certain reports or statements (for example, expert’s reports, share valuation reports, directors&#8217; reports, or other financial reports), where to do so might duplicate existing information.</p>
<p>BIS has not proposed changes in the area of strengthening creditor protection, as it considers the existing UK regime to already meet the 2009 Directive&#8217;s requirements.</p>
<p>BIS invites comments on the draft Regulations by 13 March 2011. Full details are <a title="http://www.bis.gov.uk/assets/biscore/business-law/docs/c/11-534-companies-reporting-requirements-mergers-divisions-regulations-draft" href="http://www.bis.gov.uk/assets/biscore/business-law/docs/c/11-534-companies-reporting-requirements-mergers-divisions-regulations-draft">here</a> (Word doc) and <a title="http://www.bis.gov.uk/assets/biscore/business-law/docs/e/11-535-explanatory-text-draft-companies-reporting-requirements-regulations" href="http://www.bis.gov.uk/assets/biscore/business-law/docs/e/11-535-explanatory-text-draft-companies-reporting-requirements-regulations">here</a>.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.mablaw.com/2011/01/consultation-draft-companies-reporting-requirements-in-mergers-and-divisions-regulations-2011-directive-bis-june-2011/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Chief executive of London Stock Exchange criticises proposed changes</title>
		<link>http://www.mablaw.com/2010/09/chief-executive-of-london-stock-exchange-criticises-proposed-changes/</link>
		<comments>http://www.mablaw.com/2010/09/chief-executive-of-london-stock-exchange-criticises-proposed-changes/#comments</comments>
		<pubDate>Wed, 29 Sep 2010 16:30:44 +0000</pubDate>
		<dc:creator>Emma Cameron</dc:creator>
				<category><![CDATA[Corporate]]></category>
		<category><![CDATA[Corporate Finance]]></category>
		<category><![CDATA[Mergers & Acquisitions]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[corporate]]></category>
		<category><![CDATA[corporate finance]]></category>

		<guid isPermaLink="false">http://www.mablaw.com/?p=5233</guid>
		<description><![CDATA[The Government has proposed that the United Kingdom Listing Authority (UKLA) merges with the Financial Reporting Council (FRC). Xavier Rolet, the chief executive of the London Stock Exchange (LSE) has criticised this proposal stating that it would &#8220;durably and severely damage the competitiveness&#8221; of London. The LSE is concerned that the FRC will not be [...]]]></description>
			<content:encoded><![CDATA[<p>The Government has proposed that the United Kingdom Listing Authority (UKLA) merges with the Financial Reporting Council (FRC). Xavier Rolet, the chief executive of the London Stock Exchange (LSE) has criticised this proposal stating that it would &#8220;durably and severely damage the competitiveness&#8221; of London.</p>
<p>The LSE is concerned that the FRC will not be able to deal with the real-time monitoring and response required by the UKLA&#8217;s functions and this will put London at a disadvantage compared to other markets.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.mablaw.com/2010/09/chief-executive-of-london-stock-exchange-criticises-proposed-changes/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Company directors to take note of D&amp;O insurance policies</title>
		<link>http://www.mablaw.com/2010/09/company-directors-to-take-note-of-do-insurance-policies/</link>
		<comments>http://www.mablaw.com/2010/09/company-directors-to-take-note-of-do-insurance-policies/#comments</comments>
		<pubDate>Thu, 02 Sep 2010 12:05:56 +0000</pubDate>
		<dc:creator>Emma Cameron</dc:creator>
				<category><![CDATA[Corporate]]></category>
		<category><![CDATA[Corporate Finance]]></category>
		<category><![CDATA[Directors' Duties]]></category>
		<category><![CDATA[Mergers & Acquisitions]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[Directors]]></category>
		<category><![CDATA[Mergers and acquisitions]]></category>

		<guid isPermaLink="false">http://www.mablaw.com/?p=4973</guid>
		<description><![CDATA[A Directors and Officers (D&#38;O) insurance policy is designed to protect the directors and officers of a company from losses resulting from claims made against them in relation to the performance of their duties. The Association of Investment Companies (AIC) has recently published guidance for directors of investment companies to help investment company boards obtain [...]]]></description>
			<content:encoded><![CDATA[<p>A Directors and Officers (<strong>D&amp;O</strong>) insurance policy is designed to protect the directors and officers of a company from losses resulting from claims made against them in relation to the performance of their duties.</p>
<p>The Association of Investment Companies (<strong>AIC</strong>) has recently published guidance for directors of investment companies to help investment company boards obtain the most appropriate D&amp;O policy. Whilst aimed at investment companies, the guidance highlights principles that directors of other types of company may find useful.</p>
<p>Key points of the guidance worth noting include:</p>
<ul>
<li>The board of directors should always remain responsible for arranging their own D&amp;O policies so that they are aware of what is and what is not covered. This is particularly important when subsidiary companies are involved under a group company structure.</li>
<li>If the board is made responsible for putting in place the D&amp;O cover this will help to ensure that all directors on the board are aware of what losses can and cannot be claimed against.</li>
<li>Directors should receive advice on the D&amp;O policy before making a claim as inaccurate reporting may lead to insufficient recoveries under the policy.</li>
<li>Any new directors should be provided with a copy of the D&amp;O policy.</li>
<li>Consideration should be given as to what effect a merger or acquisition may have on the D&amp;O policy.</li>
</ul>
<p>If you would like further information on D&amp;O policies, or to see the AIC’s guide in full, please do not hesitate to contact Emma Cameron, or another member of the corporate team at Matthew Arnold &amp; Baldwin LLP.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.mablaw.com/2010/09/company-directors-to-take-note-of-do-insurance-policies/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>MAB partner appointed to Wenta Board</title>
		<link>http://www.mablaw.com/2010/07/mab-matthew-arnold-baldwin-richard-phillips-wenta-board/</link>
		<comments>http://www.mablaw.com/2010/07/mab-matthew-arnold-baldwin-richard-phillips-wenta-board/#comments</comments>
		<pubDate>Thu, 08 Jul 2010 11:22:27 +0000</pubDate>
		<dc:creator>Richard Phillips</dc:creator>
				<category><![CDATA[Corporate]]></category>
		<category><![CDATA[Corporate Finance]]></category>
		<category><![CDATA[Corporate Structuring]]></category>
		<category><![CDATA[Mergers & Acquisitions]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[businesses]]></category>
		<category><![CDATA[enterprise agency]]></category>
		<category><![CDATA[SMEs]]></category>
		<category><![CDATA[Wenta]]></category>

		<guid isPermaLink="false">http://www.mablaw.com/?p=4174</guid>
		<description><![CDATA[Richard Phillips, Corporate partner at Matthew Arnold &#38; Baldwin LLP, has been appointed to Wenta’s Board of Directors. Wenta is the Enterprise Agency for Hertfordshire and Bedfordshire, and plays a significant role in supporting the local economy. It recently created two business incubation centres at Stevenage and Luton, which are designed to assist entrepreneurs, help [...]]]></description>
			<content:encoded><![CDATA[<p>Richard Phillips, Corporate partner at Matthew Arnold &amp; Baldwin LLP, has been <a href="http://www.wenta.co.uk/Richard_Phillips.html">appointed</a> to Wenta’s Board of Directors.</p>
<p><a href="http://www.wenta.co.uk/">Wenta</a> is the Enterprise Agency for Hertfordshire and Bedfordshire, and plays a significant role in supporting the local economy. It recently created two business incubation centres at Stevenage and Luton, which are designed to assist entrepreneurs, help create successful businesses and act as a source of support to new start-up companies across the two counties. Following the creation of these two centres, Wenta has been looking to strengthen its Board of Directors with accomplished professionals from the local business community.</p>
<p>Wenta’s Chief Executive, Chris Pichon, commented on Wenta’s website that the Agency is “constantly sourcing new ways to support, train and advise those involved in running start-ups and small businesses. Richard, [Steve and Julie] will be instrumental in steering the organisation forward as well as being our ambassadors in the community. We believe their experience, knowledge and skill set will help Wenta build on its successes and create new ones in the future.”</p>
<p>Richard commented: “I’m delighted to be involved, given the support Wenta offers to the local business community. As a stakeholder in local business (being a significant employer and given the wealth of businesses and owners of business that Matthew Arnold &amp; Baldwin advises), the firm has always considered the support given to growing businesses at their early stage by Wenta and other like bodies as absolutely crucial. Matthew Arnold &amp; Baldwin has been involved with Wenta since its inception and I am enthused to be able to play my part and help it continue to develop across the region.”</p>
]]></content:encoded>
			<wfw:commentRss>http://www.mablaw.com/2010/07/mab-matthew-arnold-baldwin-richard-phillips-wenta-board/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Takeover Panel publishes consultation paper</title>
		<link>http://www.mablaw.com/2010/06/takeover-panel-publishes-consultation-paper/</link>
		<comments>http://www.mablaw.com/2010/06/takeover-panel-publishes-consultation-paper/#comments</comments>
		<pubDate>Fri, 04 Jun 2010 16:23:30 +0000</pubDate>
		<dc:creator>Emma Cameron</dc:creator>
				<category><![CDATA[Capital Markets]]></category>
		<category><![CDATA[Corporate]]></category>
		<category><![CDATA[Corporate Finance]]></category>
		<category><![CDATA[Mergers & Acquisitions]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[Shareholders]]></category>
		<category><![CDATA[corporate]]></category>
		<category><![CDATA[corporate finance]]></category>
		<category><![CDATA[Mergers and acquisitions]]></category>
		<category><![CDATA[Takeover]]></category>

		<guid isPermaLink="false">http://www.mablaw.com/?p=3751</guid>
		<description><![CDATA[Following on from recent criticism of the takeover of Cadbury Plc by Kraft Foods, the Code Committee of the Takeover Panel (Committee) has published a consultation paper to discuss shortcomings in the current takeover process.  Whilst not stating actual recommendations for change, the Committee does propose potential amendments to the Takeover Code (Code) and highlights some of the key [...]]]></description>
			<content:encoded><![CDATA[<p>Following on from recent criticism of the takeover of Cadbury Plc by Kraft Foods, the Code Committee of the Takeover Panel (<strong>Committee</strong>) has published a consultation paper to discuss shortcomings in the current takeover process.  Whilst not stating actual recommendations for change, the Committee does propose potential amendments to the Takeover Code (<strong>Code</strong>) and highlights some of the key areas to be considered.  These areas include:</p>
<ul>
<li><strong>Acceptance condition thresholds</strong></li>
</ul>
<p>The Committee considers that changing the threshold at which conditions can be accepted could better reflect the views of longer term shareholders which, in turn, should (theoretically) better reflect the best interests of the company. However, the Committee also notes several issues to be considered if such changes are made, including the imposition of buying restrictions during the offer period.</p>
<ul>
<li><strong>The &#8220;disenfranchisement&#8221; of shares acquired during an offer period</strong></li>
</ul>
<p>The Committee suggests discounting votes made by those shareholders whose shares are acquired during the offer period. This could again be seen to reflect the interests of longer term shareholders, as well as reducing share trading during the offer period and thereby stabilising the share price.  The Committee also recognises the numerous potential difficulties with this proposal. For example, if an offer turns out to be unsuccessful, at which point should voting rights be reinstated?</p>
<ul>
<li><strong>Disclosures in relation to shares and other securities</strong></li>
</ul>
<p>One of the Code’s aims is to provide as much transparency in the takeover process as possible.  To this end the Committee suggests reducing the threshold at which large shareholders must disclose their interests to small shareholders with less than a 1% shareholding, as well as introducing an obligation to disclose acceptances and voting decisions. However, the Committee notes that the 1% threshold is already well below requirements contained within other codes of practice, and that a substantial increase in disclosure may result in ‘over-disclosure’ which could ultimately cause confusion.</p>
<ul>
<li><strong>Advice, advisers and advisory fees</strong></li>
</ul>
<p>In keeping with the principle of transparency, the Committee proposes that the Code should require public disclosure of advisers&#8217; fees and costs although opponents argue that sensitive information may be disclosed as a result. </p>
<ul>
<li><strong>The &#8220;put up or shut up&#8221; regime, &#8220;virtual bids&#8221; and the offer timetable.</strong></li>
</ul>
<p>The concept of ‘Put up or Shut Up’ relates to an offeree company’s ability to request the Takeover Panel to impose an offer deadline on an offeror company.  It has been suggested that such a deadline be reduced to a standard period. Critics believe that this may not be in the interests of the offeree’s shareholders as the offeree’s board may not have sufficient time to fully consider an offer.</p>
<ul>
<li><strong>Substantial acquisitions of shares</strong></li>
</ul>
<p>Following the abolition of the rules against speedy acquisitions of a company’s shares, there are arguments to reintroduce time limits under which a specified proportion of shares can be acquired. However, in response to this the Committee states that ‘market raids’ are relatively rare and it is not the role of the Takeover Panel to decide who can acquire shares.</p>
<p>The Committee has requested comments on the consultation by 27 July 2010 after which it will decide whether any reform of the Code is required.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.mablaw.com/2010/06/takeover-panel-publishes-consultation-paper/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>Kraft makes a meal of Cadbury takeover</title>
		<link>http://www.mablaw.com/2010/05/kraft-makes-a-meal-of-cadbury-takeover/</link>
		<comments>http://www.mablaw.com/2010/05/kraft-makes-a-meal-of-cadbury-takeover/#comments</comments>
		<pubDate>Fri, 28 May 2010 15:37:08 +0000</pubDate>
		<dc:creator>Emma Cameron</dc:creator>
				<category><![CDATA[Capital Markets]]></category>
		<category><![CDATA[Corporate]]></category>
		<category><![CDATA[Corporate Finance]]></category>
		<category><![CDATA[Mergers & Acquisitions]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[corporate]]></category>
		<category><![CDATA[corporate finance]]></category>
		<category><![CDATA[Mergers and acquisitions]]></category>
		<category><![CDATA[Takeover]]></category>

		<guid isPermaLink="false">http://www.mablaw.com/?p=3681</guid>
		<description><![CDATA[Following Kraft Foods’ takeover of Cadbury Plc in February 2010, the US company has had its knuckles rapped by the Takeover Panel for its conduct during the offer stage of the deal. The issue in question surrounded Cadbury Plc’s facility at Somerdale which, in 2007, Cadbury had announced would be the subject of a phased [...]]]></description>
			<content:encoded><![CDATA[<p>Following Kraft Foods’ takeover of Cadbury Plc in February 2010, the US company has had its knuckles rapped by the Takeover Panel for its conduct during the offer stage of the deal.</p>
<p>The issue in question surrounded Cadbury Plc’s facility at Somerdale which, in 2007, Cadbury had announced would be the subject of a phased closure scheme during 2009 and 2010.  In several offer documents, Kraft stated its belief that the facility could remain open.</p>
<p>These statements fell foul of the two part test contained within rule 19.1 of the Takeover Code.  This rule relates to the bidder and target upholding standards of care during the takeover process, particularly in conjunction with rule 24 of the Takeover Code, which governs the information required in the bidder’s offer documents.  In this instance, the Takeover Panel found that when declaring that the facility could remain open, Kraft should not only have honestly and genuinely believed this to be true, but should also have had a reasonable basis for making such a declaration.  Kraft failed on the second part of the test.</p>
<p>Kraft’s leading financial advisers, Lazard &amp; Co, can count themselves lucky to escape the public criticism levelled at Kraft.  Whilst the Takeover Panel deemed them to be partly responsible for failing to provide the information on which Kraft needed to rely when making the relevant statements, it did not consider it necessary to publicly criticise Lazard in the same manner as Kraft.</p>
<p>This decision by the Takeover Panel is a helpful reminder that financial advisers, as well as bidders, must at all times carefully follow the rules of the Takeover Code and should be alert to the repercussions of failing to do so.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.mablaw.com/2010/05/kraft-makes-a-meal-of-cadbury-takeover/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Court upholds &#8220;tail-gunner&#8221; clause</title>
		<link>http://www.mablaw.com/2010/05/court-upholds-tail-gunner-clause/</link>
		<comments>http://www.mablaw.com/2010/05/court-upholds-tail-gunner-clause/#comments</comments>
		<pubDate>Thu, 27 May 2010 11:32:50 +0000</pubDate>
		<dc:creator>Emma Cameron</dc:creator>
				<category><![CDATA[Corporate]]></category>
		<category><![CDATA[Corporate Finance]]></category>
		<category><![CDATA[Corporate Structuring]]></category>
		<category><![CDATA[Mergers & Acquisitions]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[corporate]]></category>
		<category><![CDATA[corporate finance]]></category>
		<category><![CDATA[Mergers and acquisitions]]></category>

		<guid isPermaLink="false">http://www.mablaw.com/?p=3658</guid>
		<description><![CDATA[Background &#8220;Tail-gunner&#8221; clauses are often used by corporate finance advisers in their terms of engagement so that if a transaction completes within a certain period after the termination of their engagement, a success fee is payable to the adviser despite the fact that they are no longer engaged at the date of completion.  The clause [...]]]></description>
			<content:encoded><![CDATA[<p><strong>Background</strong></p>
<p>&#8220;Tail-gunner&#8221; clauses are often used by corporate finance advisers in their terms of engagement so that if a transaction completes within a certain period after the termination of their engagement, a success fee is payable to the adviser despite the fact that they are no longer engaged at the date of completion.  The clause is so-called as it refers to the parting shot of a bomber finishing his sortie.  A recent case has upheld the use of such a clause.</p>
<p><strong>Facts of the case</strong></p>
<p>Grandtop International Holdings Limited (<strong>Grandtop</strong>) engaged Seymour Pierce Limited (<strong>Seymour Pierce</strong>) in June 2007 to advise on its acquisition of Birmingham City Football Club (<strong>club</strong>). It was initially envisaged that the transaction would proceed by way of a recommended takeover. The terms of engagement provided for a £2.2 million success fee and stated:</p>
<p>&#8220;In the event the engagement pursuant to this letter of engagement is terminated by the Company and an Offer for the Target is declared or becomes wholly unconditional as the result of any offer made by or in association with the Company within a period of 12 months after the effective date of termination the Company shall pay to Seymour Pierce the Success Fee in full.&#8221;</p>
<p>The transaction did not proceed in the manner which had been envisaged and Seymour Pierce&#8217;s involvement declined, resulting in their engagement being formally terminated in May 2009. Grandtop eventually completed (with input from another corporate finance adviser) its acquisition of the club in September 2009, 4 months into the &#8220;tail-gunner&#8221; period. Seymour Pierce sued for the success fee.</p>
<p><strong>Decision</strong></p>
<p>Grandtop argued that Seymour Pierce had not been the effective cause, or even one of the effective causes, of the final transaction and did not deserve the success fee. However, the court held that the terms of engagement clearly stated that the success fee was payable irrespective of whether Seymour Pierce had been responsible for completion of the transaction in its final form.</p>
<p><strong>Comment</strong></p>
<p>The case turned on the wording used in Seymour Pierce&#8217;s terms of engagement and therefore highlights the importance of careful drafting. In hindsight, Seymour Pierce’s terms seemed uncommercial and unreasonable as they resulted in Grandtop having to pay the fees of two sets of corporate finance advisers. Nonetheless, the court found in favour of Seymour Pierce. This is good news for corporate finance advisers but not for their clients who should, despite such a clause often being non-negotiable, try at least to limit its duration.</p>
<p><em>Seymour Pierce Limited v Grandtop International Holdings Limited </em><em>[2010] EWHC 676 (QB)</em><em></em></p>
]]></content:encoded>
			<wfw:commentRss>http://www.mablaw.com/2010/05/court-upholds-tail-gunner-clause/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>What has the Coalition government got in store for business?</title>
		<link>http://www.mablaw.com/2010/05/coalition-government-business-regulation-agreement/</link>
		<comments>http://www.mablaw.com/2010/05/coalition-government-business-regulation-agreement/#comments</comments>
		<pubDate>Tue, 25 May 2010 09:52:58 +0000</pubDate>
		<dc:creator>Richard Phillips</dc:creator>
				<category><![CDATA[Capital Markets]]></category>
		<category><![CDATA[Corporate]]></category>
		<category><![CDATA[Corporate Finance]]></category>
		<category><![CDATA[Corporate Restructure]]></category>
		<category><![CDATA[Corporate Structuring]]></category>
		<category><![CDATA[Directors' Duties]]></category>
		<category><![CDATA[Mergers & Acquisitions]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[Shareholders]]></category>
		<category><![CDATA[Coalition Government]]></category>
		<category><![CDATA[corporate]]></category>
		<category><![CDATA[corporate governance]]></category>
		<category><![CDATA[Directors]]></category>
		<category><![CDATA[manifestos]]></category>
		<category><![CDATA[regulation]]></category>
		<category><![CDATA[SMEs]]></category>
		<category><![CDATA[Takeover]]></category>

		<guid isPermaLink="false">http://www.mablaw.com/?p=3638</guid>
		<description><![CDATA[Before the general election, I looked at what the three main political parties were proposing for corporate governance, takeovers, businesses and regulation. All the parties had clear-cut policies in these areas. However, following the election result and subsequent formation of the coalition government, the Conservatives and Liberal Democrats have had to sit down with each [...]]]></description>
			<content:encoded><![CDATA[<p>Before the general election, I looked at <a title="Company law: where do the main political parties stand?" href="http://www.mablaw.com/2010/05/takeovers-manifesto-governance-labour-conservative-liberal-election/">what the three main political parties were proposing </a>for corporate governance, takeovers, businesses and regulation. All the parties had clear-cut policies in these areas. However, following the election result and subsequent formation of the coalition government, the Conservatives and Liberal Democrats have had to sit down with each other and reach agreement on how to move forward in these areas. This has involved both parties dropping manifesto/policy commitments and making compromises, although in other areas, both parties had similar plans. So, what has the coalition proposed?</p>
<p><span style="text-decoration: underline;">1. Tackle ‘red tape’</span></p>
<p>Before the election, both the Conservatives and Liberal Democrats promised to tackle red tape, including imposing a “one-in-one-out rule” for new regulations. This rule will now be implemented. They have also agreed to scrap the culture of “tick-box regulation” enforcement and will introduce “sunset clauses” (a Liberal Democrat policy), so that rules will expire if they are not reviewed. Finally, the Government will scrap the “gold-plating” of European legislation (i.e the transposition of EU legislation, which goes beyond what is required by that legislation.)</p>
<p><span style="text-decoration: underline;">2. Businesses</span></p>
<p>The Government aims to encourage new start-ups by reducing the number of forms needed to register a new business, so that Britain becomes the fastest place in the world to start a business (Conservative policy). It will also end the ban on social tenants starting businesses in their own homes (Conservative policy.)</p>
<p><span style="text-decoration: underline;">3. Takeovers</span></p>
<p>The Government “will review the range of factors that can be considered by regulators when takeovers are proposed.” There are currently no further details. The Conservatives’ manifesto did not explicitly deal with takeovers, but the Liberal Democrats promised to ensure that the takeover rules restored a public interest test, so that a broader range of factors, other than competition, would be considered by regulators when takeovers are proposed.</p>
<p><span style="text-decoration: underline;">4. Operating and Financial Reviews</span></p>
<p>The Government will reinstate Operating and Financial Reviews “to ensure that directors’ social and environmental duties have to be covered in company reporting, and investigate further ways of improving corporate accountability and transparency.” (Liberal Democrat policy). These Reviews were originally proposed, but then dropped, by the Labour Party in 2006.</p>
<p>It is currently early days for the Government, and their recently-published ‘Coalition Agreement’ will be implemented over the next five years. Many of the proposals lack sufficient detail at the moment, but this will surely become clearer over time. The emergency budget, which will be heard on 22 June, will be a starting point. From a small business perspective, look out for the <a title="Chancellor announces date of emergency Budget" href="http://www.mablaw.com/2010/05/chancellor-announces-date-of-emergency-budget/">capital gains tax changes</a>.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.mablaw.com/2010/05/coalition-government-business-regulation-agreement/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Company law: where do the main political parties stand?</title>
		<link>http://www.mablaw.com/2010/05/takeovers-manifesto-governance-labour-conservative-liberal-election/</link>
		<comments>http://www.mablaw.com/2010/05/takeovers-manifesto-governance-labour-conservative-liberal-election/#comments</comments>
		<pubDate>Wed, 05 May 2010 14:30:21 +0000</pubDate>
		<dc:creator>Richard Phillips</dc:creator>
				<category><![CDATA[Capital Markets]]></category>
		<category><![CDATA[Corporate]]></category>
		<category><![CDATA[Corporate Finance]]></category>
		<category><![CDATA[Corporate Restructure]]></category>
		<category><![CDATA[Corporate Structuring]]></category>
		<category><![CDATA[Mergers & Acquisitions]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[Shareholders]]></category>
		<category><![CDATA[corporate]]></category>
		<category><![CDATA[corporate governance]]></category>
		<category><![CDATA[manifestos]]></category>
		<category><![CDATA[Mergers and acquisitions]]></category>
		<category><![CDATA[SMEs]]></category>
		<category><![CDATA[Takeover]]></category>

		<guid isPermaLink="false">http://www.mablaw.com/?p=3323</guid>
		<description><![CDATA[With the general election looming, this briefing looks at what the three main political parties have proposed for corporate governance, takeovers, small and medium-sized businesses, and regulation in their recent policy statements and election manifestos. We discuss some of the main proposals below and assess the possible implications their proposals may have. 1. Corporate governance [...]]]></description>
			<content:encoded><![CDATA[<p style="text-align: left;">With the general election looming, this briefing looks at what the three main political parties have proposed for corporate governance, takeovers, small and medium-sized businesses, and regulation in their recent policy statements and election manifestos. We discuss some of the main proposals below and assess the possible implications their proposals may have.</p>
<p><span style="text-decoration: underline;">1. Corporate governance</span></p>
<p>The main political parties’ proposals were made in the aftermath of the <em>Walker Review</em>, an independent review of corporate governance in the UK banking industry, in November 2009.</p>
<p><strong>Labour </strong></p>
<p>The Labour Government welcomed the <em>Walker Review</em>, with Lord Myners, the Financial Secretary to the Treasury, commenting that the Government had to address “the weaknesses in board practice, risk management, control of remuneration and exercise of ownership rights identified by the Review…” In its manifesto, the Labour Party states that it will:</p>
<ul>
<li>Strengthen the <em>Companies Act 2006</em> “where necessary” in order to create strong businesses comprising of skilled managers, accountable boards, and committed shareholders with long-term commitment;</li>
<li>Strengthen the UK’s <em>Stewardship Code for Institutional Shareholders</em>, requiring institutional shareholders to declare how they vote, and for bank remuneration policies to be approved by shareholders.</li>
</ul>
<p> </p>
<p><strong>Conservatives</strong></p>
<p>The Conservative Party also welcomed the <em>Walker Review</em>, but criticised it for not going far enough. The Party’s manifesto says that it will:<strong> </strong></p>
<ul>
<li>Abolish the current tripartite system of regulation &#8211; abolish the FSA and put the Bank of England in charge of prudential supervision.</li>
</ul>
<p>  </p>
<p><strong>Liberal Democrats</strong></p>
<p>The Liberal Democrats also supported the <em>Walker Review</em>, but, like the Conservative Party, did not believe it went far enough. Vince Cable, the Party’s Treasury spokesman, commented at the time that the recommendations should be compulsory, not voluntary. <strong> </strong></p>
<p> </p>
<p><span style="text-decoration: underline;">2. Takeovers</span></p>
<p>The recent controversial Kraft/Cadbury takeover has brought the subject of takeovers back into the political sphere.</p>
<p><strong>Labour</strong></p>
<p>Although at the time, the Business Secretary, Lord Mandelson, said the takeover was something that had to be decided by Cadbury’s shareholders, he has now changed his position and in the last couple of months has called for a wide-ranging review of UK takeover law. The Party’s manifesto includes some proposed reforms which would have a huge impact on takeovers: </p>
<ul>
<li>Raise the threshold of shareholder support for company takeovers to a two-thirds majority, rather than the existing 50 per cent plus one share majority;</li>
<li>Examine the possibility of “limiting votes” to those on the voting register before the bid is announced;</li>
<li>Ensure that bidding companies are “more transparent” about their long-term plans for the business they want to takeover and their advisers’ fees;</li>
<li>Require bidding companies to set out how they will finance their bids;</li>
<li>More disclosure of who owns shares in the companies;</li>
<li>Extend the “public interest” test in UK merger control so that it is applied to potential takeovers of infrastructure and utility companies.</li>
</ul>
<p>  </p>
<p><strong>Conservatives</strong></p>
<p>The Conservative Party’s manifesto does not explicitly deal with takeovers. However, Shadow Business Secretary, Kenneth Clarke, commented that the Cadbury takeover was a matter for its shareholders.</p>
<p>  </p>
<p><strong>Liberal Democrats</strong></p>
<p>At the time of the Cadbury takeover, the Liberal Democrats were critical of the Government’s willingness to allow a state-controlled bank, Royal Bank of Scotland, to finance Kraft’s bid. Its manifesto proposes to:<strong> </strong></p>
<ul>
<li>Ensure that “takeover rules serve the UK economy” by restoring a public interest test, so that a broader range of factors, other than competition, can be considered by regulators when takeovers are proposed;</li>
<li>Ensure that the outcome of takeover bids are determined by the long-term shareholder base.</li>
</ul>
<p><strong> </strong> </p>
<p><span style="text-decoration: underline;">3. Small and medium-sized businesses</span></p>
<p><strong>Labour</strong> </p>
<ul>
<li>New UK Finance for Growth, which will use £4bn billion of public and private funds to help businesses looking to develop and grow, in exchange for an equity stake in the company;</li>
<li>Growth Capital Fund, announced in the last Budget, will inject money into, small and medium-sized companies in businesses with turnovers of between £1m and £25m.</li>
</ul>
<p>  </p>
<p><strong>Conservatives</strong></p>
<p>Although there are no direct manifesto commitments, the Conservative Party recently commissioned a report by the American entrepreneur Doug Richard (an ex-‘dragon’ on the BBC’s <em>Dragon’s Den</em> television programme). His report, <em>Small Business and Government: the Richard Report</em>, proposed, amongst other things, the extension of the Enterprise Investment Scheme, which helps smaller trading companies to raise money by offering tax reliefs to investors who purchase shares in the companies.</p>
<p> </p>
<p><strong>Liberal Democrats</strong></p>
<p>Establish Local Enterprise Funds and Regional Stock Exchanges. Local Enterprise Funds will help local investors put money into growing businesses in their own locality. Regional Stock Exchanges will allow businesses to access equity without the heavy regulatory requirements of a London listing;</p>
<ul>
<li>Reintroduce the Operating and Financial Review to ensure that directors’ social and environmental duties will be covered in company reporting.</li>
</ul>
<p> </p>
<p><span style="text-decoration: underline;">3. Regulatory burden</span></p>
<p><strong>Labour</strong> </p>
<ul>
<li>Seek to reduce the costs of regulation by more than £6bn by 2015.</li>
</ul>
<p>  </p>
<p><strong>Conservatives</strong></p>
<p>The Conservative Party policy document <em>Regulation in the Post-Bureaucratic Age</em>, published in October 2009, criticises the rise in regulation since Labour came to power in 1997, and proposes to: </p>
<ul>
<li>Reduce the burden of red tape on business with a &#8216;one in one out&#8217; rule for new regulation;</li>
<li>Force each government department to reduce the regulatory burden by 5 per cent each year by eradicating costly and inefficient regulation.</li>
</ul>
<p>The Conservative manifesto reiterates the need to cut the regulatory burden, and also to: </p>
<ul>
<li>Reduce the number of forms that need to be completed to register a new business. It aims to create a &#8216;one-click&#8217; registration model, so that Britain becomes the fastest place in the world to start a business;</li>
<li>End restrictions on tenants in social housing starting a business from their homes.</li>
</ul>
<p> <strong> </strong></p>
<p><strong>Liberal Democrats</strong> </p>
<ul>
<li>Cut regulation by assessing the cost and effectiveness of regulations before and after they are introduced;</li>
<li>Operate a ‘one in one out’ system so that for every regulation introduced, another one is scrapped;</li>
<li>Change the ‘culture’ of regulators to help, not hinder, business.</li>
</ul>
<p>  </p>
<p><span style="text-decoration: underline;">Comment</span></p>
<p>The election manifestos and policy statements of the three main parties have revealed some common ground and one big difference between them.</p>
<p>All the parties have welcomed the recommendations of the <em>Walker Review</em> (even if they don’t all think it has gone far enough), put forward plans to financially help small and medium-sized businesses, and made commitments to cut regulatory burden.</p>
<p>However, differences emerge on the issue of takeovers – a sensitive subject in the wake of the Cadbury takeover by Kraft. Labour has promised to bring in a ‘Cadbury law’ to protect British companies from foreign takeovers, whilst the Liberal Democrats want to create a ‘public interest’ test to ensure that issues other than just competition are taken into account when deciding whether a takeover should be allowed. The Conservatives, on the other hand, have rejected calls to change the UK takeover rules at all.</p>
<p>The proposed changes by Labour and the Liberal Democrats, if brought in, would have a big impact on how takeovers are conducted and potentially make it more difficult for bidders to succeed. Consequently, business leaders, as well as lawyers, are awaiting the outcome of the election with even greater interest than usual.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.mablaw.com/2010/05/takeovers-manifesto-governance-labour-conservative-liberal-election/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Account of profits sometimes claimable as remedy for breach of confidentiality and sometimes not, depending on the nature of the duty – Vercoe v Rutland, High Court</title>
		<link>http://www.mablaw.com/2010/03/account-of-profits-sometimes-claimable-as-remedy-for-breach-of-confidentiality-and-sometimes-not-depending-on-the-nature-of-the-duty-%e2%80%93-vercoe-v-rutland-high-court/</link>
		<comments>http://www.mablaw.com/2010/03/account-of-profits-sometimes-claimable-as-remedy-for-breach-of-confidentiality-and-sometimes-not-depending-on-the-nature-of-the-duty-%e2%80%93-vercoe-v-rutland-high-court/#comments</comments>
		<pubDate>Thu, 25 Mar 2010 10:40:05 +0000</pubDate>
		<dc:creator>Paul Gershlick</dc:creator>
				<category><![CDATA[Commercial Contracts]]></category>
		<category><![CDATA[Corporate]]></category>
		<category><![CDATA[Corporate Restructure]]></category>
		<category><![CDATA[Corporate Structuring]]></category>
		<category><![CDATA[Intellectual Property]]></category>
		<category><![CDATA[MBOs & MBIs]]></category>
		<category><![CDATA[Mergers & Acquisitions]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[Upload-Commercial/IP/IT]]></category>
		<category><![CDATA[account of profits]]></category>
		<category><![CDATA[breach]]></category>
		<category><![CDATA[breach of contract]]></category>
		<category><![CDATA[confidential information]]></category>
		<category><![CDATA[confidentiality]]></category>
		<category><![CDATA[contract]]></category>
		<category><![CDATA[contract law]]></category>
		<category><![CDATA[contracts]]></category>
		<category><![CDATA[damages]]></category>
		<category><![CDATA[fiduciary duty]]></category>
		<category><![CDATA[Intellectual property]]></category>
		<category><![CDATA[intellectual property rights]]></category>
		<category><![CDATA[Mergers and acquisitions]]></category>
		<category><![CDATA[tort]]></category>

		<guid isPermaLink="false">http://www.mablaw.com/?p=2856</guid>
		<description><![CDATA[V&#38;P had approached R about a possible acquisition of a company called H&#38;T. V&#38;P and R had entered into a confidentiality agreement about this. In breach of that agreement, R bought H&#38;T without even contacting V&#38;P. R later sold on H&#38;T at a massive profit. The High Court agreed that R had breached the duty [...]]]></description>
			<content:encoded><![CDATA[<p>V&amp;P had approached R about a possible acquisition of a company called H&amp;T. V&amp;P and R had entered into a confidentiality agreement about this. In breach of that agreement, R bought H&amp;T without even contacting V&amp;P. R later sold on H&amp;T at a massive profit. The High Court agreed that R had breached the duty of confidentiality, but the big question it had to rule on was whether V&amp;P could just claim for damages for the breach of duty of confidentiality or whether it could also make a claim for R to account for its big profits. Damages would be for the loss of the notional transaction by effectively buying a release from V&amp;P for their rights.</p>
<p>The High Court ruled that account of profits could sometimes be claimed for breach of confidentiality, but not in this case. It all depended on the circumstances. Duties of confidentiality related to a big range of possible situations. As to whether an account of profits was available as a remedy depended on the particular type of situation and whether it would be just and equitable that the defendant should retain absolutely no profit from that particular type of situation. The nature of a duty of confidentiality could apply in the following big variety of situations:</p>
<ul>
<li>Akin to a fiduciary duty.</li>
<li>Akin to an intellectual property right.</li>
<li>Arising out of a contractual duty.</li>
<li>In relation to use of private information obtained from a stranger, and therefore a situation similar to tort.</li>
</ul>
<p>In this case, there was no fiduciary relationship or intellectual property right type situation and so an account of profits was not appropriate. The relationship was based on a contractual relationship. Therefore, damages was the appropriate remedy rather than V&amp;P having the right to claim an account of profits.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.mablaw.com/2010/03/account-of-profits-sometimes-claimable-as-remedy-for-breach-of-confidentiality-and-sometimes-not-depending-on-the-nature-of-the-duty-%e2%80%93-vercoe-v-rutland-high-court/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Kraft/Cadbury deal prompts calls for reform of takeover laws</title>
		<link>http://www.mablaw.com/2010/03/kraftcadbury-deal-prompts-calls-for-reform-of-takeover-laws/</link>
		<comments>http://www.mablaw.com/2010/03/kraftcadbury-deal-prompts-calls-for-reform-of-takeover-laws/#comments</comments>
		<pubDate>Wed, 10 Mar 2010 11:58:10 +0000</pubDate>
		<dc:creator>Emma Cameron</dc:creator>
				<category><![CDATA[Capital Markets]]></category>
		<category><![CDATA[Corporate]]></category>
		<category><![CDATA[Corporate Finance]]></category>
		<category><![CDATA[Corporate Restructure]]></category>
		<category><![CDATA[Corporate Structuring]]></category>
		<category><![CDATA[Mergers & Acquisitions]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[Shareholders]]></category>
		<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[corporate]]></category>
		<category><![CDATA[corporate finance]]></category>
		<category><![CDATA[Directors]]></category>
		<category><![CDATA[Mergers and acquisitions]]></category>
		<category><![CDATA[Takeover]]></category>

		<guid isPermaLink="false">http://www.mablaw.com/?p=2489</guid>
		<description><![CDATA[The hostile takeover of the British chocolate maker, Cadbury plc (Cadbury) by US company, Kraft Foods Inc (Kraft) has been widely publicised, especially the initial resistance by Cadbury’s shareholders to the deal. In the end, a sufficient percentage of Cadbury’s shareholders (90%) accepted Kraft’s increased final offer and “squeezed out” the remaining minority shareholders, allowing [...]]]></description>
			<content:encoded><![CDATA[<p>The hostile takeover of the British chocolate maker, Cadbury plc (<strong>Cadbury</strong>) by US company, Kraft Foods Inc (<strong>Kraft</strong>) has been widely publicised, especially the initial resistance by Cadbury’s shareholders to the deal. In the end, a sufficient percentage of Cadbury’s shareholders (90%) accepted Kraft’s increased final offer and “squeezed out” the remaining minority shareholders, allowing the takeover to proceed.</p>
<p>Peter Mandelson (the Business Secretary) has since proposed various reforms to takeover laws including:</p>
<ul>
<li>raising the voting threshold required to approve a hostile bid</li>
<li>denying short-term shareholders such as hedge funds the right to vote during a bid period</li>
<li>giving bidders less time to formally commit to their offer (“put up or shut up”) so as to reduce the length of time a takeover bid takes to complete</li>
<li>requiring bidders to set out publicly how they intend to finance their bids over the long term and how they intend to make cost savings</li>
</ul>
<p>The proposals have, however, received a mixed response. Some commentators are in favour of protecting companies from hostile bids but others would prefer takeover laws to remain the same so as to allow a company’s shareholders (rather than its board of directors) to determine the outcome of a takeover bid.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.mablaw.com/2010/03/kraftcadbury-deal-prompts-calls-for-reform-of-takeover-laws/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>Tax TV</title>
		<link>http://www.mablaw.com/2010/02/tax-tv/</link>
		<comments>http://www.mablaw.com/2010/02/tax-tv/#comments</comments>
		<pubDate>Thu, 18 Feb 2010 15:02:23 +0000</pubDate>
		<dc:creator>Shimon Shaw</dc:creator>
				<category><![CDATA[Commercial Contracts]]></category>
		<category><![CDATA[Corporate]]></category>
		<category><![CDATA[Corporate Structuring]]></category>
		<category><![CDATA[Data Protection & Privacy (Other Sectors)]]></category>
		<category><![CDATA[Employers]]></category>
		<category><![CDATA[Helping your business]]></category>
		<category><![CDATA[Intellectual Property]]></category>
		<category><![CDATA[Joint Ventures]]></category>
		<category><![CDATA[LLP]]></category>
		<category><![CDATA[Manufacturing]]></category>
		<category><![CDATA[Mergers & Acquisitions]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[Shareholders]]></category>
		<category><![CDATA[Tax]]></category>
		<category><![CDATA[Tax Issues]]></category>
		<category><![CDATA[contract]]></category>
		<category><![CDATA[contracts]]></category>
		<category><![CDATA[copyright]]></category>
		<category><![CDATA[corporate]]></category>
		<category><![CDATA[data protection]]></category>
		<category><![CDATA[intellectual property rights]]></category>
		<category><![CDATA[tax]]></category>

		<guid isPermaLink="false">http://www.mablaw.com/?p=2283</guid>
		<description><![CDATA[In what seems to me to be a slightly odd use of taxpayer&#8217;s money, HMRC have decided to sponsor a new channel 5 TV show &#8211; the Business Inspector. The justification of this is that the programme will raise awareness among small businesses that they need to keep good records. The show will aim to [...]]]></description>
			<content:encoded><![CDATA[<p>In what seems to me to be a slightly odd use of taxpayer&#8217;s money, HMRC have decided to sponsor a new channel 5 TV show &#8211; the Business Inspector.</p>
<p>The justification of this is that the programme will raise awareness among small businesses that they need to keep good records.  The show will aim to help Britain’s small businesses improve their all round business knowledge and direction, cash flow, marketing strategy and in some cases even their enthusiasm.</p>
<p>The show will start in March, but if you can&#8217;t wait until then the good news is that here at MAB we have a business health check product which might prove even more useful than a TV show&#8230;.<a href="http://www.mablaw.com/wp-content/uploads/2010/02/Business-Healthcheck-Fast-Facts.pdf">Click here for info on our Business Healthcheck</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.mablaw.com/2010/02/tax-tv/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

